- Home
- ADAG vs CHMI Comparison
ADAG vs CHMI Comparison
Compare ADAG & CHMI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- CHMI
- Stock Information
- Founded
- ADAG 2011
- CHMI 2012
- Country
- ADAG China
- CHMI United States
- Employees
- ADAG N/A
- CHMI N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- CHMI Real Estate Investment Trusts
- Sector
- ADAG Health Care
- CHMI Real Estate
- Exchange
- ADAG Nasdaq
- CHMI Nasdaq
- Market Cap
- ADAG 81.9M
- CHMI 84.8M
- IPO Year
- ADAG 2021
- CHMI 2013
- Fundamental
- Price
- ADAG $1.60
- CHMI $3.04
- Analyst Decision
- ADAG Strong Buy
- CHMI Hold
- Analyst Count
- ADAG 1
- CHMI 2
- Target Price
- ADAG $8.00
- CHMI N/A
- AVG Volume (30 Days)
- ADAG 15.4K
- CHMI 272.3K
- Earning Date
- ADAG 03-24-2025
- CHMI 05-06-2025
- Dividend Yield
- ADAG N/A
- CHMI 19.74%
- EPS Growth
- ADAG N/A
- CHMI N/A
- EPS
- ADAG N/A
- CHMI N/A
- Revenue
- ADAG $103,204.00
- CHMI $27,506,000.00
- Revenue This Year
- ADAG $6,488.89
- CHMI N/A
- Revenue Next Year
- ADAG $57.50
- CHMI $32.55
- P/E Ratio
- ADAG N/A
- CHMI N/A
- Revenue Growth
- ADAG N/A
- CHMI 19.59
- 52 Week Low
- ADAG $1.33
- CHMI $2.34
- 52 Week High
- ADAG $3.58
- CHMI $3.99
- Technical
- Relative Strength Index (RSI)
- ADAG 51.88
- CHMI 54.73
- Support Level
- ADAG $1.51
- CHMI $2.91
- Resistance Level
- ADAG $1.74
- CHMI $3.03
- Average True Range (ATR)
- ADAG 0.10
- CHMI 0.12
- MACD
- ADAG 0.03
- CHMI 0.05
- Stochastic Oscillator
- ADAG 61.84
- CHMI 89.69
About ADAG Adagene Inc.
Adagene Inc platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity as highlighted by the company's immunotherapy pipeline.
About CHMI Cherry Hill Mortgage Investment Corporation
Cherry Hill Mortgage Investment Corp operates as a real estate investment trust in the United States. It invests in residential mortgage assets to generate current yields and risk-adjusted total returns for its stockholders over the long term, primarily through dividend distributions and secondarily through capital appreciation. The company's reportable segments include investments in Residential mortgage-backed securities (RMBS), Investments in Servicing Related Assets, and All Others. It generates maximum revenue from the RMBS segment in the form of Interest income earned for servicing mortgage loans.